Tiffany Tolmie | Manager, Investor Relations |
Mark Murray | Chief Executive Officer |
William Symonds | Chief Development Officer |
Koert VandenEnden | Interim CFO |
Katherine Xu | William Blair |
Keay Nakae | Chardan |
Good day, ladies and gentlemen, and welcome to the Arbutus Biopharma Corporation 2018 First Quarter Financial Results and Corporate Update. [Operator Instructions] As a reminder today's program is being recorded. And now I'd like to introduce your host for today's program, Tiffany Tolmie, Manager of Investor Relations. Please go ahead.
Good afternoon and thank you for joining us as we review our first quarter 2018 financial results and provide a corporate update.